Increased inhibition of inward rectifier K+ channels by angiotensin II in small-diameter coronary artery of isoproterenol-induced hypertrophied model

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 8, 2007, Pages 1768-1775

  Park, Won Sun ^a   Ko, Jae Hong ^a   Kim, Nari ^a   Son, Youn Kyoung ^a   Kang, Sung Hyun ^a   Warda, Mohamad ^a   Jung, In Duk ^b   Park, Yeong Min ^b   Han, Jin ^a  

^a Inje University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Angiotensin II; Hypertrophy; Inward rectifier K+ channel; Microcirculation; PKC

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; INWARDLY RECTIFYING POTASSIUM CHANNEL; ISOPRENALINE; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASODILATATION; ANIMAL; CELL CULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; ELECTROPHYSIOLOGY; HYPERTROPHIC CARDIOMYOPATHY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROBABILITY; RABBIT; RANDOMIZATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CARDIOMYOPATHY, HYPERTROPHIC; CELLS, CULTURED; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; ENDOTHELIUM, VASCULAR; MALE; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROBABILITY; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 34547626373     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.143339     Document Type: Article

References (50)

1. Kohya T, Kimura S, Myerburg RJ, Bassett AL. Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischemia. J Mol Cell Cardiol. 1988;20:159-168.
2. Pye MP, Cobbe SM. Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res. 1992;26:740-750.
3. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88:993-1003.
4. Hittinger L, Mirsky I, Shen YT, Patrick TA, Bishop SP, Vatner SF. Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation. 1995;92:978-986.
5. Burke AP, Farb A, Liang YH, Smialek J, Virmani R. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation. 1996;94:3138-3145.
6. Kaufmann P, Vassalli G, Lupi-Wagner S, Jenni R, Hess OM. Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol. 1996;28:745-750.
7. + channels of the coronary artery during left ventricular hypertrophy. Circ Res. 2003;93:541-547.
8. + current of rabbit coronary arterial myocytes in isoproterenol-induced hypertrophy. Korean J Physiol Pharmacol. 2001;5:33-40.
9. + channels. J Physiol. 1996;492:419-430.
10. Quayle JM, Dart C, Standen NB. The properties and distribution of inward rectifier potassium currents in pig coronary arterial smooth muscle. J Physiol. 1996;494:715-726.
11. + channels by hypoxia in rabbit coronary arterial smooth muscle cells. Am J Physiol. 2005a;289:H2461-H2467.
12. Hughes AD, Bolton TB. Action of angiotensin II, 5-hydroxytryptamine and adenosine triphosphate on ionic currents in single ear artery cells of rabbit. Br J Pharmacol. 1995;116:2148-2154.
13. Ohya Y, Sperelakis N. Involvement of a GTP-binding protein in stimulating action of angiotensin II on calcium channels in vascular smooth muscle cells. Circ Res. 1991;68:763-771.
14. 2+ channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002. Pflügers Arch. 1999;437:317-323.
15. + current in rabbit vascular myocytes. J Physiol. 1996;495:689-700.
16. ATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Cε. J Physiol. 2001a;530:193-205.
17. + channels of rat arterial smooth muscle. Am J Physiol. 2001b;281:H2480-H2489.
18. + currents in rat arterial smooth muscle cells through protein kinase C. J Physiol. 1997;503:489-496.
19. Toro L, Amador M, Stefani E. ANG II inhibits calcium activated potassium channels from coronary smooth muscle in lipid bilayers. Am J Physiol. 1990;258:H912-H915.
20. + channel by angiotensin II and endothelin-1. Biochem Pharmacol. 1995;49:1051-1056.
21. + channels in rabbit coronary arterial smooth muscle cells through protein kinase Cα. Biochem Biophys Res Commun. 2006a;341:728-735.
22. Kim NR, Lee YS, Kim HK, Joo H, Youm JB, Park WS, Warda M, Cuong DV, Han J. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics. 2006;6:1237-1249.
23. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res. 1994;28:933-946.
24. +-induced cerebral vasodilatation in vivo. Am J Physiol. 2000;279:H2704-H2712.
25. + channels in rabbit coronary arterial smooth muscle cells through protein kinase C. J Cardiovasc Pharmacol. 2005b;46:681-689.
26. Johnson JA, Gray MO, Chen CH, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem. 1996;271:24962-24966.
27. Benjamin JJ, Jabil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
28. Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res. 1994;75:105-113.
29. Gillis AM, Mathison HJ, Patel C, Lester WM. Quinidine pharmacodynamics in normal and isoproterenol-induced hypertrophied bloodperfused working rabbit hearts. J Cardiovasc Pharmacol. 1996;27:916-926.
30. Ji Y, Huang Y, Han Y, Xu Y, Ferro A. Cardiac effects of amiloride and of enalapril in the spontaneously hypertensive rats. J Hypertens. 2003;21:1583-1589.
31. 2+-handling proteins in heart hypertrophy. Toxicol Appl Pharmacol. 2005;207:244-256.
32. Kleiman RB, Houser SR. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol. 1988;255:H1434-H1442.
33. Nordin C, Siri F, Aronson SR. Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol. 1989;21:729-739.
34. K differs in feline left ventricular hypertrophy. Am J Physiol. 1994;266:H1121-H1131.
35. Meszaros J, Ryder KO, Hart G. Transient outward current in catecholamine-induced cardiac hypertrophy in the rat. Am J Physiol. 1996;271:H2360-H2367.
36. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Hohle S, Meffert S, Stoll M, Stroth U, Zhu YZ. Angiotensin receptors. J Hypertens. 1996;14:S95-S103.
37. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
38. Ca) channels. Hypertension. 2001;37:301-307.
39. 1 angiotensin receptor in cardiac hypertrophy: angiotensin II receptor or stretch sensor?. Trends Endocrinol Metab. 2004;15:405-408.
40. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci. 2006;103:17985-17990.
41. Matsusaka H, Kinugawa S, Ide T, Matushima S, Shiomi T, Kubota T, Sunagawa K, Tsutsui H. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction. J Cardiovasc Pharmacol. 2006;48:95-102.
42. Zhang C, Yasuno S, Kuwahara K, Zankov DP, Kobori A, Makiyama T, Horie M. Blockade of angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy. Circ J. 2006;70:335-341.
43. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res. 1996;78:806-812.
44. Dessy C, Matsuda N, Hulvershorn J, Sougnez CL, Sellke FW, Morgan KG. Evidence for involvement of the PKC-alpha isoform in myogenic contractions of the coronary microcirculation. Am J Physiol. 2000;279:H916-H923.
45. Braz JC, Bueno OF, De Windt LJ, Molkentin JD. PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signaling regulated kinase1/2 (ERK1/2). J Cell Biol. 2002;156:905-919.
46. Kerkela R, Ilves M, Pikkarainen S, Tokola H, Ronkainen J, Vuolteenaho O, Leppaluoto J, Ruskoaho H. Identification of PKCalpha isoform-specific effects in cardiac myocytes using antisense phosphorothioate oligonucleotides. Mol Pharmacol. 2002;62:1482-1491.
47. ATP and Kir channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun. 2006b;340:1104-1110.
48. +-ATPase dilation. Circ Res. 1990;67:1035-1039.
49. Marrelli SP, Johnson TD, Khorovets A, Childres WF, Bryan RM Jr. Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion. Stroke. 1998;29:1469-1474.
50. Tiyyagura SR, Pinney SP. Left ventricular remodeling after myocardial infarction: past, present, and future. Mt Sinai J Med. 2006;73:840-851.